US Patent 9528136 Methods of modifying eukaryotic cells
Patent 9528136 was granted and assigned to Regeneron Pharmaceuticals on December, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 25, 2013
Date of Patent
December 27, 2016
Patent Applicant
Patent Application Number
14036892
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9528136 Methods of modifying eukaryotic cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
